Wellgistics Health (NASDAQ:WGRX) Rating Increased to Hold at Wall Street Zen

Key Points

• Wellgistics Health was upgraded from a "sell" to a "hold" rating by Wall Street Zen, reflecting adjusted analysts' outlook on the company's stock.
• The company's stock opened at $0.9450 with a 12-month low of $0.6150 and high of $7.04, emphasizing significant volatility over the past year.
• Wellgistics Health reported ($0.11) earnings per share and generated $7.79 million in revenue during its last quarterly earnings report.

Wall Street Zen upgraded shares of Wellgistics Health (NASDAQ:WGRX - Free Report) from a sell rating to a hold rating in a report released on Friday.

Wellgistics Health Stock Performance

WGRX stock traded down $0.21 during midday trading on Friday, hitting $1.34. 2,331,376 shares of the stock were exchanged, compared to its average volume of 6,776,413. The stock's 50-day moving average is $0.95. Wellgistics Health has a fifty-two week low of $0.62 and a fifty-two week high of $7.04. The company has a debt-to-equity ratio of 11.16, a quick ratio of 0.11 and a current ratio of 0.32.

Wellgistics Health (NASDAQ:WGRX - Get Free Report) last issued its quarterly earnings data on Tuesday, August 19th. The company reported ($0.11) earnings per share (EPS) for the quarter. The company had revenue of $7.79 million during the quarter.

About Wellgistics Health

Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services.